Asthma

>

Latest News

 Atopic Dermatitis First, Now Onto Asthma for Enveda's Oral Small Molecule Anti-inflammatory Candidate
Atopic Dermatitis First, Now Onto Asthma for Enveda's Oral Small Molecule Anti-inflammatory Candidate

February 7th 2025

The investigational molecule with “JAK-inhibitor-like efficacy and IL4/IL13-like safety,” was cleared in Q4 2024 by the FDA for an IND application, the company said.

Albuterol/Budesonide Reduces Risk of Exacerbation in People with Intermittent, Mild-Persistent Asthma
Albuterol/Budesonide Reduces Risk of Exacerbation in People with Intermittent, Mild-Persistent Asthma

October 7th 2024

States with Higher COVID-19 Vaccination Rates Saw Reduction in Pediatric Asthma Prevalence / Image credit: ©Alessandro Grandini/AdobeStock
States with Higher COVID-19 Vaccination Rates Saw Reduction in Pediatric Asthma Prevalence

July 9th 2024

Phase III Trials Show Depemokimab Reduces Severe Asthma Exacerbations with Twice-Yearly Dosing / image credit ©freshidea/stock.adobe.com
Phase III Trials Show Depemokimab Reduces Severe Asthma Exacerbations with Twice-Yearly Dosing

June 12th 2024

Find and Treat Asthma and COPD: All Interventions Make a Difference, Study Concludes ©Crystal Light/stock.adobe.com
Find and Treat Asthma and COPD: All Interventions Make a Difference, Study Concludes

May 22nd 2024

More News

© 2025 MJH Life Sciences

All rights reserved.